In a joint effort, EASL, together with the International Liver Transplantation Society (ILTS) and the American Association for the Study of Liver Diseases (AASLD), is launching a survey aimed at transplant centres worldwide on the utilization of HbsAg-positive organs in…
The 2-day meeting in Chicago on 8-9 July 2022 convened 129 consensus survey participants in person or online. The participants originated from 32 countries, representing multiple societies including AASLD, EASL, APASL, ALEH, AGA and UEG, patients and patient advocacy organizations,…
Four societies focused on liver disease research and treatment announced a global call-to-action initiative to simplify hepatitis C testing and treatment. BOSTON, 8 November 2019. The societies, in partnership with the Clinton Health Access Initiative (CHAI), launched the initiative at…
Researchers have identified how DNA methylation is associated with a condition known as non-alcoholic fatty liver disease (NAFLD), which can lead to liver cirrhosis and death, and is one of the leading indicators for liver transplants. DNA methylation is a…